Glutathione is also essential for maintaining energy levels and aids in the recovery process after physical exertion, making it a favorite among athletes and those with active lifestyles
No published trials compare outcomes between standard-start and loading-dose regimens
During early treatment, some experience mild nausea, bloating, or digestive changes that generally resolve within the first few weeks as the body adapts to the medication
Why it matters: A larger research signal is not the same as a settled treatment option
The takeaway: most people will not experience this side effect, and for non-diabetic patients, the overall risk is considered extremely low
Cagrilintide is the first long-acting amylin analog to reach Phase 3 trials, with fatty acid acylation enabling once-weekly dosing compared to the three-times-daily dosing required by the older amylin analog pramlintide